Nasonex 50micrograms/dose nasal spray

Riik: Suurbritannia

keel: inglise

Allikas: MHRA (Medicines & Healthcare Products Regulatory Agency)

Toimeaine:

Mometasone furoate

Saadav alates:

Organon Pharma (UK) Ltd

ATC kood:

R01AD09

INN (Rahvusvaheline Nimetus):

Mometasone furoate

Annus:

50microgram/1dose

Ravimvorm:

Spray

Manustamisviis:

Nasal

Klass:

No Controlled Drug Status

Retsepti tüüp:

Valid as a prescribable product

Toote kokkuvõte:

BNF: 12020100; GTIN: 5012376022932

Infovoldik

PACKAGE LEAFLET: INFORMATION FOR THE USER
NASONEX® 50 MICROGRAMS/ACTUATION NASAL SPRAY, SUSPENSION
Mometasone Furoate
PLEASE READ THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you. Do not pass it on to
others. It may harm them, even if
their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects
not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Nasonex is and what it is used for
2.
What you need to know before you use Nasonex
3.
How to use Nasonex
4.
Possible side effects
5.
How to store Nasonex
6.
Contents of the pack and other information
1. WHAT NASONEX IS AND WHAT IT IS USED FOR
WHAT IS NASONEX?
Nasonex Nasal Spray contains mometasone furoate, one of a group of
medicines called corticosteroids.
When mometasone furoate is sprayed into the nose, it can help to
relieve inflammation (swelling and
irritation of the nose), sneezing, itching and a blocked up or runny
nose.
WHAT IS NASONEX USED FOR?
Hayfever and perennial rhinitis
Nasonex is used to treat the symptoms of hayfever (also called
seasonal allergic rhinitis) and perennial
rhinitis in adults and children aged 3 and older.
Hayfever, which occurs at certain times of the year, is an allergic
reaction caused by breathing in pollen
from trees, grasses, weeds and also moulds and fungal spores.
Perennial rhinitis occurs throughout the
year and symptoms can be caused by a sensitivity to a variety of
things including house dust mite, animal
hair (or dander), feathers and certain foods. Nasonex reduces the
swelling and irritation in your nose and
thereby relieving sneezing, itching and a blocked-up or runny nose
caused by hayfever or perennial
rhinitis.
Nasal polyps
Nasonex is used to treat nasal polyps in adults aged 18 and over.

Toote omadused

OBJECT 1
NASONEX 50 MICROGRAMS/ACTUATION NASAL SPRAY,
SUSPENSION
Summary of Product Characteristics Updated 18-Dec-2017 | Merck Sharp &
Dohme Limited
1. Name of the medicinal product
NASONEX® 50 micrograms/actuation Nasal Spray, Suspension
2. Qualitative and quantitative composition
Mometasone furoate (as the monohydrate) 50 micrograms/actuation.
Excipient with known effect
This medicinal product contains 0.02 mg of benzalkonium chloride per
actuation.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Nasal Spray, Suspension.
White to off-white opaque suspension.
4. Clinical particulars
4.1 Therapeutic indications
NASONEX Nasal Spray is indicated for use in adults and children 3
years of age and older to treat the
symptoms of seasonal allergic or perennial rhinitis.
NASONEX Nasal Spray is indicated for the treatment of nasal polyps in
adults 18 years of age and older.
4.2 Posology and method of administration
After initial priming of the NASONEX Nasal Spray pump, each actuation
delivers approximately 100 mg
of mometasone furoate suspension, containing mometasone furoate
monohydrate equivalent to 50
micrograms mometasone furoate.
POSOLOGY
Seasonal Allergic or Perennial Rhinitis
Adults (including older patients) and children 12 years of age and
older: The usual recommended dose is
two actuations (50 micrograms/actuation) in each nostril once daily
(total dose 200 micrograms). Once
symptoms are controlled, dose reduction to one actuation in each
nostril (total dose 100 micrograms) may
be effective for maintenance. If symptoms are inadequately controlled,
the dose may be increased to a
maximum daily dose of four actuations in each nostril once daily
(total dose 400 micrograms). Dose
reduction is recommended following control of symptoms.
Children between the ages of 3 and 11 years: The usual recommended
dose is one actuation (50
micrograms/actuation) in each nostril once daily (total dose 100
micrograms).
NASONEX Nasal Spray demonstrated a clinically significant onset of
action within 12 hours